Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Webinar Co-Hosted with Bioanalysis Zone
Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant? BioAgilytix’s Global CSO, Dr. Arno Kromminga addresses this subject and more.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
2 Days Agoview on linkedin
While CAR-T cell therapy offers exciting opportunities for treating solid tumors, it also can evoke cytokine release syndrome (CRS) cytotoxicity. Learn about the panels we use to monitor various cytokine levels throughout CAR-T therapy: https://lnkd.in/ei_ef-2
2 Days Agoview on linkedin
Interested in applying your scientific expertise to support the development of promising new large molecule drugs? Consider joining our Durham, NC team as a Scientist I, II, or III. View the qualifications and how you can apply: https://lnkd.in/ezxzjCQ
5 Days Agoview on linkedin
At the Cambridge Healthtech Institute Immuno-Oncology Summit Europe on Monday, Dr. Arno Kromminga will lead a discussion on biomarker use in regulated bioanalysis in immuno-oncology. Make sure you mark your calendars for 18 March at 17:15 to hear his scientific perspective. https://lnkd.in/ewQHfSs
March 15, 2019New FDA Guidance on Developing and Validating Assays for ADA Detection: Key Updates and Clarifications
March 12, 2019Key Takeaways from Oxford Global’s 14th Annual Biomarkers Congress
February 7, 2019BioAgilytix Welcomes Lydia Michaut, Ph.D. to Team as Scientific Officer
January 1, 2019BioAgilytix Announces Several Promotions within Its Leadership Team
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
